Press Releases

Welcome to the Investing News Network's press release section, where you can stay informed with past and present announcements from our clients. Explore the latest stock news from mining, technology and life science companies and gain an investing edge by staying up to date with today's press releases.
Filters
Clear All Filters
Filter ✕

Date Range

Sector

Cardiol Therapeutics (CRDL:CA)

New Data from the Phase II ARCHER Trial Demonstrate CardiolRx Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions

Biotech Investing

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

Pharmaceutical Investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Accelerates Eventdex Integration; Expands AI Matchmaking and Achieves Milestone Production of 800 Interactive Floor Plans in 2025

Artificial Intelligence Investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Poised for Growth as Event-Tech and 3D/AR Revenue Accelerates

Artificial Intelligence Investing
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040

Biotech Investing
InMed Pharmaceuticals (INM)

InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value

pharmaceuticals investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys

artificial intelligence investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys

Artificial Intelligence Investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Provides Update on Toggle3D.ai

Artificial Intelligence Investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai and Arway Provide Business Combination Update

Artificial Intelligence Investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Provides Update on Toggle3D.ai

Artificial Intelligence Investing

InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases

Biotech Investing
Nextech3D.ai (NTAR:CNX)

Nextech3D.ai: Disrupting the Global Events Management Industry with AI and Blockchain

Artificial Intelligence Investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Reports Strong 20% Q2 Sequential Revenue Growth With Gross Margins of 88% For the Three Months Ended September 30, 2025

Artificial Intelligence Investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Reports Milestone YTD Revenue Growth for AI Matchmaking in 2025 with a 95% Gross Margin

Artificial Intelligence Investing
Nextech3D.ai (NTAR:CC)

Nextech3D.ai Reports Milestone YTD Revenue Growth for AI Matchmaking in 2025 with a 95% Gross Margin

Artificial Intelligence Investing
Solvonis Therapeutics (None)

Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth

pharmaceutical investing
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027

Biotech Investing
Cardiol Therapeutics (CRDL:CA)

Canadian Investment Regulatory Organization Trade Resumption - CRDL

Biotech Investing

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES